Status:
COMPLETED
The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery
Lead Sponsor:
Xijing Hospital
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
The investigators previously investigated the cardioprotective effect of an adenosine-lidocaine cardioplegia with moderate-potassium (K+, 10.0 mmol/L) in pediatric cardiac surgery, which was associate...
Eligibility Criteria
Inclusion
- pediatric patients (body weight\<10 kg)
- congenital heart diseases and scheduled for a repair operation with CPB in the Department of Cardiovascular Surgery, Xijing Hospital.
Exclusion
- other systemic diseases
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01479049
Start Date
October 1 2009
End Date
October 1 2010
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiovascular Surgery, Xijing Hospital
Xi'an, Shaanxi, China, 710032